GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
Taiwan
· Delayed Price · Currency is TWD 40.00
-1.60 (-3.85%)
Mar 9, 2026, 1:30 PM CST
GeneFerm Biotechnology Revenue
In the year 2025, GeneFerm Biotechnology had annual revenue of 677.10M TWD with 29.92% growth. GeneFerm Biotechnology had revenue of 177.21M in the quarter ending December 31, 2025, with 14.34% growth.
Revenue
677.10M
Revenue Growth
+29.92%
P/S Ratio
2.45
Revenue / Employee
4.70M
Employees
144
Market Cap
1.66B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 677.10M | 155.94M | 29.92% |
| Dec 31, 2024 | 521.16M | -272.61M | -34.34% |
| Dec 31, 2023 | 793.77M | 159.81M | 25.21% |
| Dec 31, 2022 | 633.96M | 111.63M | 21.37% |
| Dec 31, 2021 | 522.33M | 154.03M | 41.82% |
| Dec 31, 2020 | Pro | Pro | Pro |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Tien Liang BioTech | 467.02M |
| InnoPharmax | 55.77M |
| TSH Biopharm Corporation | 1.34B |
| Winston Medical Supply | 724.35M |
| DV Biomed | 712.61M |
| Golden Biotechnology | 44.58M |
| Excelsior Biopharma | 898.26M |
| Johnson Chemical Pharmaceutical Works | 567.06M |